Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis

• Status: Recruiting
• Trial end date: 2022-06-30
• Target enrollment: 0
• Participant gender: All

Summary

Phase 2 Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Applied Molecular Transport

Criteria

Inclusion Criteria:

• Chronic or recurrent pouchitis

Exclusion Criteria:

• Known gastrologic, or systemic condition that may compromise severity or diagnosis of disease.

• History or current evidence of colonic or abdominal abnormalities.

• Previous exposure to AMT-101 or similar and known hypersensitivity to AMT-101 or its excipients.